Alembic Pharmaceuticals gains on getting final nod for Paclitaxel Injection from USFDA

27 Oct 2022 Evaluate

Alembic Pharmaceuticals is currently trading at Rs. 549.20, up by 1.05 points or 0.19% from its previous closing of Rs. 548.15 on the BSE.

The scrip opened at Rs. 551.25 and has touched a high and low of Rs. 552.35 and Rs. 542.50 respectively. So far 7803 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 847.95 on 04-Jan-2022 and a 52 week low of Rs. 541.10 on 20-Oct-2022.

Last one week high and low of the scrip stood at Rs. 559.70 and Rs. 541.10 respectively. The current market cap of the company is Rs. 10814.90 crore.

The promoters holding in the company stood at 69.61%, while Institutions and Non-Institutions held 17.87% and 12.52% respectively.

Alembic Pharmaceuticals has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Paclitaxel Injection USP, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL) Multiple-Dose Vials. This is the first product approval for oncology injection from F-2 Facility (Oncology Injectable) which recently completed the first USFDA inspection.

The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Taxol Injection, 30 mg/5 mL (6 mg/mL), 100 mg/16.7 mL (6 mg/mL), and 300 mg/50 mL (6 mg/mL). Paclitaxel Injection USP, has an estimated market size of $26 million for twelve months ending June 2022. Alembic has a cumulative total of 172 ANDA approvals (148 final approvals and 24 tentative approvals) from USFDA.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.

Alembic Pharma Share Price

842.85 -0.30 (-0.04%)
30-Dec-2025 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.15
Dr. Reddys Lab 1264.05
Cipla 1495.00
Zydus Lifesciences 904.30
Lupin 2098.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×